Response to “Denosumab and Romosozumab do not increase the risk of cardiovascular events in patients with primary osteoporosis: A reanalysis of the meta-analysis”

Fang Lv, Xiaoling Cai*, Linong Ji

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

1 Citation (Scopus)
Original languageEnglish
Article number115271
JournalBone
Volume134
DOIs
Publication statusPublished - May 2020
Externally publishedYes

Cite this